{"id":24646,"date":"2022-09-19T20:17:26","date_gmt":"2022-09-20T00:17:26","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_scientists&#038;p=24646"},"modified":"2023-02-13T15:30:35","modified_gmt":"2023-02-13T20:30:35","slug":"ansuman-t-satpathy-md-phd","status":"publish","type":"cri_scientists","link":"https:\/\/www.cancerresearch.org\/es\/cri-funded-scientists\/ansuman-t-satpathy-md-phd","title":{"rendered":"Ansuman T. Satpathy, MD, PhD"},"content":{"rendered":"\n<p>The goal of Dr. Satpathy\u2019s research is to develop and apply genome-scale technologies to study fundamental properties of the immune system in cancer immunity and immunotherapy. In his proposal, Dr. Satpathy will focus on three research programs over the next 5 years: (1) to develop and employ multi-omic single-cell and longitudinal profiling methods to understand the transcriptional and epigenetic regulation of immune cell types, lineage trajectories of immune differentiation and clonal response, and dysfunctional pathways that can arise in cancer, (2) use gene- and epigenome-editing methods to interrogate protein-coding and noncoding regulators of the immune response, particularly T cell exhaustion and dysfunction, and to engineer improved cellular immunotherapies, and (3) develop and use tools from functional genomics and mass spectrometry to discover novel regulators of host-cancer interactions that regulate anti-tumor immunity.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Projects and Grants<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Single-Cell Epigenome Technologies for Cancer Immunotherapy<\/h3>\n\n\n\n<p>Stanford University | All Cancers | 2020<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Genomic approaches for novel cancer immunotherapies<\/h3>\n\n\n\n<p>Stanford University | All Cancers | 2022<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The goal of Dr. Satpathy\u2019s research is to develop and apply genome-scale technologies to study fundamental properties of the immune system in cancer immunity and immunotherapy. In his proposal, Dr. Satpathy will [&hellip;]<\/p>\n","protected":false},"featured_media":2683,"template":"","tax_cancer_type":[455],"tax_grant_type":[482],"tax_award_year":[479],"tax_institutions":[513],"tax_location_states":[501],"class_list":["post-24646","cri_scientists","type-cri_scientists","status-publish","has-post-thumbnail","hentry"],"acf":{"scientist_subhead":"CRI Lloyd J. Old STAR","quote":"","scientist_last_name":"Satpathy","show_on_landing":true,"scientist_publish_until":"20270630"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ansuman T. Satpathy, MD, PhD<\/title>\n<meta name=\"description\" content=\"Dr. Satpathy is employing novel single-cell sequencing technologies to identify the key gene regulatory mechanisms that underlie immunotherapy resistance in patients with basal cell carcinoma, which has a 30% response rate.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ansuman T. Satpathy, MD, PhD\" \/>\n<meta property=\"og:description\" content=\"Dr. Satpathy is employing novel single-cell sequencing technologies to identify the key gene regulatory mechanisms that underlie immunotherapy resistance in patients with basal cell carcinoma, which has a 30% response rate.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-13T20:30:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/59dba178-de8e-414b-a4e6-bcbef74d2d4a.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"440\" \/>\n\t<meta property=\"og:image:height\" content=\"440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd\",\"url\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd\",\"name\":\"Ansuman T. Satpathy, MD, PhD\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/59dba178-de8e-414b-a4e6-bcbef74d2d4a.jpg\",\"datePublished\":\"2022-09-20T00:17:26+00:00\",\"dateModified\":\"2023-02-13T20:30:35+00:00\",\"description\":\"Dr. Satpathy is employing novel single-cell sequencing technologies to identify the key gene regulatory mechanisms that underlie immunotherapy resistance in patients with basal cell carcinoma, which has a 30% response rate.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/59dba178-de8e-414b-a4e6-bcbef74d2d4a.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/59dba178-de8e-414b-a4e6-bcbef74d2d4a.jpg\",\"width\":440,\"height\":440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ansuman T. Satpathy, MD, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ansuman T. Satpathy, MD, PhD","description":"Dr. Satpathy is employing novel single-cell sequencing technologies to identify the key gene regulatory mechanisms that underlie immunotherapy resistance in patients with basal cell carcinoma, which has a 30% response rate.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd","og_locale":"es_ES","og_type":"article","og_title":"Ansuman T. Satpathy, MD, PhD","og_description":"Dr. Satpathy is employing novel single-cell sequencing technologies to identify the key gene regulatory mechanisms that underlie immunotherapy resistance in patients with basal cell carcinoma, which has a 30% response rate.","og_url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd","og_site_name":"Cancer Research Institute","article_modified_time":"2023-02-13T20:30:35+00:00","og_image":[{"width":440,"height":440,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/59dba178-de8e-414b-a4e6-bcbef74d2d4a.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd","url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd","name":"Ansuman T. Satpathy, MD, PhD","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/59dba178-de8e-414b-a4e6-bcbef74d2d4a.jpg","datePublished":"2022-09-20T00:17:26+00:00","dateModified":"2023-02-13T20:30:35+00:00","description":"Dr. Satpathy is employing novel single-cell sequencing technologies to identify the key gene regulatory mechanisms that underlie immunotherapy resistance in patients with basal cell carcinoma, which has a 30% response rate.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/59dba178-de8e-414b-a4e6-bcbef74d2d4a.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/59dba178-de8e-414b-a4e6-bcbef74d2d4a.jpg","width":440,"height":440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/ansuman-t-satpathy-md-phd#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Ansuman T. Satpathy, MD, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"fimg_url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/59dba178-de8e-414b-a4e6-bcbef74d2d4a.jpg","_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists\/24646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_scientists"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/2683"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=24646"}],"wp:term":[{"taxonomy":"tax_cancer_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_cancer_type?post=24646"},{"taxonomy":"tax_grant_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_grant_type?post=24646"},{"taxonomy":"tax_award_year","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_award_year?post=24646"},{"taxonomy":"tax_institutions","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_institutions?post=24646"},{"taxonomy":"tax_location_states","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_location_states?post=24646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}